Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - cancer+stem+cells
7
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Compounds and Methods for Treating Cancer by Destroying
Cancer Stem Cells
(UCLA Case No. 2021-286)
Researchers from UCLA’s Department of Chemistry and Biochemistry and the Department of Radiation Oncology have synthesized a set of compounds for the eradication of
cancer stem cells
. These compounds are predicted to cross the blood brain barrier and show promise as effective interventions for glioblastoma in both in vitro and in vivo assays. BACKGROUND:...
Published: 7/11/2024
|
Inventor(s):
Michael Jung
,
Frank Pajonk
Keywords(s):
blood-brain barrier
,
Brain
,
Cancer
,
Cancer stem cells
,
drug screening
,
GBM
,
Glioblastoma
,
Glioma
,
new chemical entity
Category(s):
Therapeutics > Oncology
,
Therapeutics > CNS and Neurology
,
Therapeutics > Stem Cells And Regenerative Medicine
Full Spectrum Computer Vision for Photon Counting CT (Case No. 2024-058)
Summary: Researchers in the Department of Radiological Sciences have developed a machine learning algorithm that processes multispectral photon counting CT data for accurate medical imaging. Background: Photon counting computed tomography (PCCT) is a tremendous engineering advancement, enabling high resolution spectral imaging with myriad applications....
Published: 9/20/2024
|
Inventor(s):
Matthew Brown
,
Dieter Enzmann
,
John Hoffman
,
Michael Mcnitt-Gray
Keywords(s):
AI algorithms
,
Algorithm
,
Algorithm Optical Coherence Tomography
,
algorithmic cancer detection
,
Artifical Intelligence (Machine Learning, Data Mining)
,
artificial electromagnetic materials
,
Artificial Intelligence
,
artificial intelligence augmentation
,
Artificial Neural Network
,
Artificial Neural Network Artificial Neuron
,
artificial-intelligent materials
,
Big Data
,
Bladder Cancer
,
blood cancers
,
Brain cancer
,
Breast Cancer
,
Cancer
,
cancer antigen
,
cancer detection
,
Cancer Immunotherapy
,
Cancer stem cells
,
cancer target
,
Computed tomography
,
CT
,
Deep Learning
,
design software
,
Digital Pathology
,
generative artificial intelligence
,
Genetic Algorithm
,
Histopathological image analysis
,
Histopathology
,
histopathology images
,
hyperparameter optimization
,
Image Analysis
,
Image Processing
,
lympathic cancers
,
lymphatic cancer
,
Medical artificial intelligence (AI)
,
Mesenchymal Stem Cell Derived Cancer Cells
,
Orthotopic cancer models
,
Pancreatic cancer
,
pathology image analysis
,
Photon counting computed tomography (PCCT)
,
prostate cancer
,
Radiology
,
Radiology / Radiomitigation
,
Software
,
Software & Algorithms
,
Software Development Tools
,
Software-enabled learning
Category(s):
Software & Algorithms
,
Software & Algorithms > Image Processing
,
Software & Algorithms > Artificial Intelligence & Machine Learning
,
Software & Algorithms > Data Analytics
Inhibition of BMI1 Eliminated
Cancer Stem Cells
and Activates Antitumor Immunity (UCLA Case No. 2020-858)
UCLA researchers in the Department of Dentistry discovered that targeting BMI1in head and neck squamous cell carcinoma (HNSCC) may be a viable immune checkpoint to inhibit metastatic tumor growth, and prevent tumor relapse through activation of cell-intrinsic immunity and purging
cancer stem cells
(CSCs). BACKGROUND: Cancer stem cells are cancer...
Published: 3/6/2024
|
Inventor(s):
Cun-Yu Wang
,
Jia Lingfei
Keywords(s):
Cancer stem cells
,
Epigenetics
,
Immunooncology
,
Oncology Immunotherapy
,
Tumor
Category(s):
Therapeutics > Oncology > Oncology Immunotherapy
,
Therapeutics > Gene Therapy And Editing
Method for Combined Conditioning and Chemoselection in a Single Cycle (UCLA Case No. 2011-478)
SUMMARY: Researchers at UCLA have developed a highly-efficient technique to engraft and select hematopoietic stem cells directly inside a patient. The invention will improve the fidelity of stem cell transplantations and reduce toxic side effects on patients. BACKGROUND: Hematopoietic stem cell transplantation (HSCT) is a mainstay of treatment for...
Published: 11/15/2024
|
Inventor(s):
Gay Crooks
,
Robert Schiestl
,
Katrin Hacke
,
Akos Szakmary
Keywords(s):
blood cancers
,
Cancer stem cells
,
Hematopoietic stem cell transplantation
,
hematopoietic stem cells
,
lymphatic cancer
,
stem cell transplantations
,
Transplant
Category(s):
Therapeutics > Stem Cells And Regenerative Medicine
,
Therapeutics > Transplant
Targeted Epigenetic Editing as Novel Therapy for Malignant Glioma (UCLA Case No. 2023-047)
UCLA Researchers in the Department of Neurology/Neuro-Oncology and the David Geffen School of Medicine have developed methods for the Cas9-CRISPR mediated epigenetic targeting of malignant glioma, and which results in enhanced chemosensitivity to standard chemotherapeutic agents. BACKGROUND: Malignant gliomas are aggressive brain tumors originating...
Published: 1/17/2024
|
Inventor(s):
Serendipity Zapanta Rinonos
,
Albert Lai
Keywords(s):
Brain
,
Cancer
,
Cancer stem cells
,
Chemotherapy
,
Combination therapy
,
CRISPR
,
CRISPR-Cas9
,
Epigenetics
,
GBM
,
Glioma
Category(s):
Therapeutics > Oncology
,
Therapeutics > CNS and Neurology
Substituted Quinoline Analogs as Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors
Aldehyde dehydrogenase enzymes (ALDHs) have a broad spectrum of biological activities through the oxidation of both endogenous and exogenous aldehydes. Unbalanced biological activity of ALDHs has been associated with a variety of disease states such as alcoholic liver disease, Parkinson’s disease, obesity, and Cancer. Increased expression of ALDH1A1...
Published: 10/28/2024
|
Inventor(s):
Anton Simeonov
,
David Maloney
,
Natalia Martinez
,
Adam Yasgar
,
Shyh-Ming Yang
Keywords(s):
1A1
,
3D spheroid
,
ALDEFLUOR assay
,
Aldehyde
,
ALDH
,
ALDH1A1
,
cancer stem cells
,
combined treatment
,
DEHYDROGENASE
,
high-content imaging
,
high-throughput screening
,
Inhibitors
,
liver
,
METABOLIC
,
MOLECULE
,
OBESITY
,
OV-90
,
Parkinson
,
RESISTANT
,
SKOV-3
,
Small
Category(s):
Collaboration Sought > Collaboration
,
Collaboration Sought > Licensing
Nanoparticle RNA Vaccine That Targets Slow-Cycling, Treatment-Resistant Cancer
Activates T-Cell Recognition of Tumor-Initiating Stem Cells in Mouse Model of Glioma This nanoparticle vaccine targets the slow-cycling, treatment-resistant,
cancer stem cells
to improve efficiency of anti-cancer drugs, thereby improving disease prognosis. Despite major developments in the field of anti-cancer therapies, tumor recurrence and metastasis...
Published: 2/13/2024
|
Inventor(s):
Elias Sayour
,
Loic Deleyrolle
,
Hector Mendez-Gomez
,
Sadeem Qdaisat
,
Duane Mitchell
Keywords(s):
Cancer
,
cancer stem cells
,
Immunotherapy
,
Nanoparticles
,
Vaccine development
Category(s):
Technology Classifications > Human Health Care > Therapeutics